Navigation Links
Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
Date:6/22/2011

here is a high unmet need for faster, more effective and safe antidepressants to help the millions of patients poorly served by current agents.  We look forward to reporting the results of this first assessment of the potential efficacy of GLYX-13 in patients with treatment-resistant depression during 2012."

In preclinical studies, GLYX-13 has demonstrated the robust antidepressant-like activity of ketamine, including its rapid onset and long duration of effect, with no signs of side effects.  It also achieved the widest therapeutic ratio between efficacy and side effects (>500:1) of any known NMDAR modulator.  

In a Phase I trial, GLYX-13 was well tolerated, with adverse events for the groups receiving GLYX-13 and placebo all rated as mild.  There were no signs of the schizophrenia-like side effects associated with other drugs that modulate the NMDAR.

For more information about the GLYX-13 Phase II trial, see http://clinicaltrials.gov/ct2/show/NCT01234558?term=glyx-13&rank=2.

About NaurexNaurex Inc. is a clinical-stage private company developing novel therapies to address unmet needs in psychiatry and neurology based on a new mechanism of action for modulating the NMDA receptor in a safe way -- Glycine-site Functional Partial Agonists (GFPAs).  In preclinical studies, Naurex's lead product, GLYX-13, has shown promising signs of rapid-acting, long-lasting antidepressant activity with excellent safety, and the safety results have been confirmed in a Phase I clinical trial.  Naurex is currently conducting a Phase II trial to assess GLYX-13 in patients who have had an inadequate response to an existing antidepressant treatment.  Naurex's second-generation program, which comprises novel patented GFPA chemistry classes with key molecular features, represents a platform for the development of new therapies for a va
'/>"/>

SOURCE Naurex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression
2. Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects
3. Cebix Initiates Phase 1b Clinical Trial with Drug Candidate Ersatta™
4. American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates
5. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
6. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
7. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
8. American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter
9. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
10. BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device
11. Vista Partners Initiates Coverage on Helix BioPharma Corporation; Target Price $6.20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014 Juno Therapeutics today announced ... to the company,s JCAR015 chimeric antigen receptor product ... relapsed or refractory B-cell acute lymphoblastic leukemia and ... Kettering Cancer Center, where Phase 1 clinical trials ... action is important news for patients who may ...
(Date:11/24/2014)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced today that Sergio Traversa , chief executive ... "MAIN Event" Micro-Cap Growth Conference on Wednesday, December 3, ... Sunset Bel Air Hotel, which is located at 11461 ... . The presentation is scheduled for 8:30 ...
(Date:11/24/2014)... , Nov. 24, 2014  GlySens Incorporated announced ... million dollar grant from the National Institute of Diabetes ... the National Institutes of Health (NIH).  The grant is ... second generation ICGM™ long term implantable glucose monitoring system.  ... and enrollment is expected to begin before the end ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Relmada Therapeutics To Present At LD MICRO Conference 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2
... ,, MINNEAPOLIS , July 8 Protectus Medical Devices, ... today it has received Notice of Allowance from the US Patent and ... self-sheathing Safety Syringe, a major step toward it becoming the ... , , ...
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
Cached Medicine Technology:US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 2US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others 3Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3
(Date:11/26/2014)... November 26, 2014 Medical suction and ... out of 5. This score represents steady growth in ... years to 2014 as a result of swelling demand ... machines, which are largely considered nondiscretionary. IBISWorld market research ... buyers have some degree of flexibility, given the low ...
(Date:11/26/2014)... News Facts , Lexmark’s ... RSNA 2014 in Chicago. The company will demonstrate ... images, photos, videos and documents found throughout the ... learn more about these innovative medical content management ... initiatives – that enable more informed clinical decisions, ...
(Date:11/26/2014)... 2014 (HealthDay News) -- Vultures have developed highly specialized ... when eating dead animals, researchers report. The new ... the faces and in the guts of 50 turkey ... average, the faces of the vultures had more than ... their guts, the study found. The findings suggest ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, 2014 ... Food and Drug Administration will have many restaurant chains posting ... to movie theater popcorn and ice cream parlor fare. ... home, often consuming less nutritious food and underestimating the calories ... Monday afternoon news conference. Although listing calorie counts ...
(Date:11/24/2014)... From embedded sensors and biometrics to elite training ... take center stage at the FitnessTech Summit , presented ... 2015 International CES® , January 6, 2015 in Las Vegas ... The bond between fitness and technology is stronger than ever ... more about the human body. , “Fitness technology has become ...
Breaking Medicine News(10 mins):Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4
... Fitness announced,that it has successfully emerged from chapter ... months after filing for bankruptcy protection on July ... Partners,Master Fund I, Ltd. and Harbinger Capital Partners ... Harbinger invested approximately $233.6 million in exchange for ...
... A visionary leader, Dr.,Maria Cristina Escobar ... outstanding contributions to the prevention and control ... 27th Pan American Sanitary Conference,proceedings today. The ... is bestowed upon creative leaders whose commitment ...
... With record supplies,of influenza vaccine expected to be ... Johnson today urged Pennsylvanians -- especially,those in high- ... by,getting a flu shot. "The flu is ... children and individuals with certain medical conditions,",explained Dr. ...
... (Nasdaq: LMAT ), a provider of peripheral vascular ... agreement to launch a,direct sales force in Italy in ... in Italy through an,exclusive distribution agreement with Serom Medical ... exclusive rights on,January 25, 2008 in exchange for the ...
... are chronically infected with hepatitis B will die from its ... Stanford University School of Medicine has identified the most cost-effective ... hepatitis B often don,t know it, because they can go ... group most likely to be infected with hepatitis B - ...
... entities in the addiction treatment field announced the launch ... (ACTION) Campaign for the improvement of addiction treatment services. ... addiction treatment for individuals in need and to keep ... during National Recovery Month in September, has a goal ...
Cached Medicine News:Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 2Health News:Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds 3Health News:Inter-American Leadership Award Bestowed Upon Chilean Chronic Disease Expert 2Health News:Health Secretary Urges Pennsylvanians to Get a Flu Shot 2Health News:LeMaitre Vascular to Start Italian Sales Force 2Health News:LeMaitre Vascular to Start Italian Sales Force 3Health News:Stanford researchers find way to fight treacherous hepatitis B 2Health News:Stanford researchers find way to fight treacherous hepatitis B 3Health News:Stanford researchers find way to fight treacherous hepatitis B 4Health News:Leaders in addiction treatment announce national 'ACTION' campaign 2
...
...
... an easy way to eliminate paper ECG ... money. This Windows-based tool dramatically streamlines ECG ... and the hospital emergency department. You can ... Review high-resolution waveforms on-screen. Edit patient information, ...
... communications software, including Remote Link and Central ... you the tools and choices to effectively ... Send patient tests via email, LAN or ... Philips Zymed Holter analysis applications are used. ...
Medicine Products: